Susan Hasty, Publisher
Table of Contents . . . March 3rd, 1997Non-Subscriber - Summaries Only
Conference Coverage (Retrovirus) - CD4 Count Still Best Marker of Immune Function
Conference Coverage (Retrovirus) - Hope Dims for Therapeutic Use of Env-Based HIV Vaccines
Conference Coverage (Retrovirus) - MAC Vaccine Enters Trials in HIV+ Adults, Children
Conference Coverage (Retrovirus) - TB Vaccination or Infection Down-Regulates Specific Subset of T Cells
Conference Coverage (Retrovirus) - Th2 Cytokines Linked to Poor Anti-HIV CTL Response in Children
Colorectal Cancer - Patient Enrollment in Phase II Vaccine Trial Completed
Human Papillomavirus - Physicians Begin Testing First HPV Vaccine
Immunotherapy (Melanoma) - Vaccines Engineered to Secrete IL-2 or gammaIFN Show Anticancer Potential
Industry News (Joint Venture) - Collaboration Extended To Develop Cancer Vaccines
Plasmodium falciparum (Immunology) - Existence of Malaria Superantigen Appears Unlikely
Therapy (GBC-590) - Lead Carbohydrate Compound Trials To Prevent Metastasis Begin
Adult Immunization - "Influenza and Tetanus Immunization."
Cancer Vaccines - "Intranasal Immunization with CTL Epitope Peptides from HIV-1 or Ovalbumin and the Mucosal Adjuvant Cholera Toxin Induces Peptide-Specific CTLs and Protection Against Tumor Development in vivo."
Immunogenetics - "IMGT, the International ImMunoGeneTics Database."
Statistical Analysis - "Optimal Vaccination Strategies - For Whom?."
Statistical Analysis - "Optimal Vaccination Strategies for a Community of Households."
Vaccine Development - "Engineering of Cholera Toxin A-Subunit for Carriage of Epitopes at Its Amino End."